CatSci Attending CPHI Frankfurt 2022

Oct 11th 2022
CatSci Attending CPHI Frankfurt 2022

CatSci Ltd is pleased to share that we will be attending the CPHI Event in Frankfurt, Germany on 1 – 3 November 2022. This is one of the biggest international pharmaceutical industry events, and we are delighted to be networking with the community.

This 3-day in-person event will be attended by:

Jenn Clark, our Head of Customer Acquisition
• Dr Jas Douville, our Head of Business Development in North America
• Dr João Madeira, our Head of Business Development in Europe
• Dr Jenny Wallis, our Head of Business Development in UK and Japan
• Dr Sofia C. Papadouli, our Senior Marketing and Communications Manager

The team are looking forward to discussing CatSci’s capabilities and how we can de-risk your journey from molecule to medicine to expedite the delivery of life-changing therapeutics.

As we continue our ambitious expansion plans following our significant investment from Keensight, we are increasing our capabilities to meet our customers’ ever-evolving needs. We continue to develop our chemistry, manufacturing and controls (CMC) capability and capacity to become an end-to-end partner for innovation in the non-clinical development of medicines.

We see ourselves as an extension of our customers’ capabilities and take the time to understand external project objectives and provide perfect-for-purpose solutions through a unique consultative approach, refined workflows and technical expertise. We leverage our highly qualified technical staff and state-of-the-art facilities to empower our customers to create affordable, best-in-class small molecule therapeutics in a safer, greener and more cost-effective way.

Arrange a meeting with CatSci now to find out how we can address your dynamic portfolio challenges and deliver your pharmaceutical pipeline without surprises or delays.

Book a meeting with us now by contacting us here.